Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression.

NCT00335205 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT00335205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00335205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar I and II Depression.
Lead sponsor
Sheba Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2003
Completion date
Not reported
Enrollment
60
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, major depressive disorder